OTCPK:IVST

Stock Analysis Report

Executive Summary

Innovest Global, Inc. engages in the commercial and industrial, energy, and biotechnology and health services sectors.


Snowflake Analysis

Mediocre balance sheet with weak fundamentals.

Share Price & News

How has Innovest Global's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IVST has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

6.6%

IVST

1.3%

US Building

1.2%

US Market


1 Year Return

-63.2%

IVST

34.4%

US Building

24.2%

US Market

Return vs Industry: IVST underperformed the US Building industry which returned 35.5% over the past year.

Return vs Market: IVST underperformed the US Market which returned 24.7% over the past year.


Shareholder returns

IVSTIndustryMarket
7 Day6.6%1.3%1.2%
30 Day-15.2%3.1%3.5%
90 Day-18.4%7.5%11.7%
1 Year-63.2%-63.2%36.4%34.4%26.9%24.2%
3 Year1364.5%1364.5%27.7%21.5%53.0%43.2%
5 Year-46.3%-46.3%58.5%38.3%75.3%56.0%

Price Volatility Vs. Market

How volatile is Innovest Global's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Innovest Global undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Innovest Global is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Innovest Global has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of IVST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Innovest Global regulatory filings here.
  • Explore potentially undervalued companies in the Capital Goods industry.

Future Growth

How is Innovest Global forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.5%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Innovest Global has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of IVST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Innovest Global's filings and announcements here.
  • Explore growth companies in the Capital Goods industry.

Past Performance

How has Innovest Global performed over the past 5 years?

15.8%

Historical Capital Goods annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Innovest Global has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Innovest Global's financial position?


In this section we usually analyse Innovest Global's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Innovest Global has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of IVST’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Innovest Global's financial data was last updated here.
  • Explore more healthy companies in the Capital Goods industry.

Dividend

What is Innovest Global's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate IVST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IVST's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IVST's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IVST's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IVST's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Innovest Global's salary, the management and board of directors tenure and is there insider trading?

1.3yrs

Average management tenure


CEO

Dan Martin 0

2.4yrs

Tenure

0

Mr. Dan Martin is Founder of Innovest Global, Inc. and has been Chairman of the Board and Chief Executive Officer at Innovest Global, Inc. since August 2017. Mr. Martin begin leading execution of a targete ...


Management Age and Tenure

1.3yrs

Average Tenure

Experienced Management: IVST's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Age and Tenure

2.3yrs

Average Tenure

58yo

Average Age

Experienced Board: IVST's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Management Team

  • Kirk Reed (53yo)

    Chief Accounting Officer and Director

    • Tenure: 11yrs
  • Monica Sheridan (58yo)

    Secretary

    • Tenure: 11yrs
  • Indrani Egleston

    Executive VP & CFO

    • Tenure: 0.3yrs
  • Wayne Bailey

    President

    • Dwain Morris-Irvin

      President of Biotech & Health Services Division

      • Dan Martin

        Founder

        • Tenure: 2.4yrs
      • Mike Yukich

        Consultant

        • Tenure: 0.3yrs
      • Damon Mintz

        President & Director

        • Tenure: 0.3yrs

      Board Members

      • Kirk Reed (53yo)

        Chief Accounting Officer and Director

        • Tenure: 11yrs
      • Monica Sheridan (58yo)

        Secretary

        • Tenure: 11yrs
      • Wayne Bailey

        President

        • Tiburcio Lopez (64yo)

          Director

          • Tenure: 6.5yrs
        • John Klopp

          Independent Director

          • Tenure: 2.1yrs
        • Dan Martin

          Founder

          • Tenure: 2.4yrs
        • Jason Painley

          Independent Director

          • Tenure: 2yrs
        • Damon Mintz

          President & Director

          • Tenure: 0.3yrs
        • Tim Figley

          Director

          • Tenure: 0.3yrs

        Company Information

        Innovest Global, Inc.'s company bio, employee growth, exchange listings and data sources


        Key Information

        • Name: Innovest Global, Inc.
        • Ticker: IVST
        • Exchange: OTCPK
        • Founded: 1999
        • Industry: Building Products
        • Sector: Capital Goods
        • Market Cap: US$24.020m
        • Shares outstanding: 149.10m
        • Website: https://www.innovestglobal.com

        Location

        • Innovest Global, Inc.
        • 8834 Mayfield Road
        • Suite 150
        • Chesterland
        • Ohio
        • 44026
        • United States

        Listings

        TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
        IVSTOTCPK (Pink Sheets LLC)YesCommon StockUSUSDMar 2007

        Biography

        Innovest Global, Inc. engages in the commercial and industrial, energy, and biotechnology and health services sectors. It designs, engineers, tests, and manufactures curtain wall systems; supplies personal protection equipment, apparel, and safety supplies; offers inbound and outbound call services; negotiates and purchases various exterior building products. The company also provides energy services to reduce businesses overall energy costs; and LED lighting products, as well as acts as independent energy broker. In addition, it develops immunotherapeutic for treating patients with glioblastoma multiforme. The company was formerly known as Aurum Resource and Asset Management, Inc. and changed its name to Innovest Global, Inc. in January 2017. Innovest Global, Inc. was incorporated in 1999 and is based in Chesterland, Ohio. 


        Company Analysis and Financial Data Status

        All financial data provided by Standard & Poor's Capital IQ.
        DataLast Updated (UTC time)
        Company Analysis2020/01/21 00:13
        End of Day Share Price2020/01/17 00:00
        Earnings2011/12/31
        Annual Earnings2011/12/31


        Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.